-
AI, Machine Learning & Computational Biology2 weeks agoSTAT+: Recipients of gene-edited pig kidneys successfully receive human organs
STAT+: Recipients of gene-edited pig kidneys successfully receive human organs
-
AI, Machine Learning & Computational Biology2 weeks ago‘Tactical athletes’ get new guidance for cardiovascular fitness
‘Tactical athletes’ get new guidance for cardiovascular fitness
-
Uncategorized2 weeks agoNew webinar: Tackling drug discovery challenges in cancer research
Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery...
-
Uncategorized2 weeks ago
Psilocybin proves promising in neuropathic pain mouse study
Amid the rise of psychedelics in the mental health space, researchers have begun to explore psilocybin as a treatment for chemotherapy-induced peripheral neuropathy.
-
Uncategorized2 weeks ago
New Spectrometry Technique Could Aid Formulation Development
New Spectrometry Technique Could Aid Formulation Development
-
AI, Machine Learning & Computational Biology2 weeks agoUniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
UniQure, after setbacks, seeks FDA approval of Huntington’s gene therapy
-
Uncategorized2 weeks ago
Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
Fortrea has agreed to acquire the early-phase services division of fellow CRO Worldwide Clinical Trials for $45 million.
-
Uncategorized2 weeks agoPartners explore T cell engaging approaches for solid tumours
Evotec and Plectonic Biotech have announced a research collaboration to explore a novel immunotherapy approach for solid tumours. The collaboration aims to address key challenges that...
-
Uncategorized2 weeks ago
Tavneos no longer available for new patients in UK as Amgen awaits FDA hearing
CSL Vifor holds the marketing authorization for Tavneos in the U.K., where the drug is marketed as Avacopan Vifor. It continues to be sold on the...
-
Uncategorized2 weeks ago
Biopharma reverse mergers rise 1,600% in Q3 to rival IPOs
Almost as many biotechs have opted for a reverse merger to reach the public markets as those executing more traditional initial public offerings this year.
Ensuring safety and accountability in China’s biomedical translation system
Blood centers can help biopharma scale cell and gene therapies
Psychedelics at FDA, Mike Davis’ CDER and translating tRNAs — a BioCentury podcast
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
